EXPLANATORY STATEMENT
National Health Act 1953
National Health (Pharmaceutical Benefits) Regulations (Amendment)
Apart from section 140 of the National Health Act 1953 (the Act), which provides that the Governor-General may make regulations for purposes of the Act, certain other provisions in the Act also specifically provide for matters to be prescribed by Regulation. Paragraph 105(a) of the Act provides that the regulations may prescribe the terms and conditions subject to which pharmaceutical benefits may be supplied.
The proposed Regulations amend regulation 25 of the National Health (Pharmaceutical Benefits) Regulations to extend the permissible period between the filling of a prescription and the next repeat prescription of the same drug from the next day to three clear days. This amendment curbs the potential for hoarding or squirrelling of drugs towards the end of the Safety Net year. Under the provisions of Division 1A of the Act the Safety Net provides to persons or families who purchase 25 prescriptions within a calendar year free pharmaceutical benefits for the remainder of that year.
The amendment, however, also allows for the further supply of a benefit within the three days where a medical practitioner so prescribes that supply is necessary for the treatment of the person, and in those cases where the benefit is destroyed, lost or stolen. The supplier is required appropriately to endorse and sign the prescription where a second supply is made within the three days.
The amendment to regulation 25 is to commence on 1 November 1990.
S.R. 363/90
Overview
The National Health Act 1953, enacted by the Commonwealth Parliament, addresses the need for comprehensive health policies and regulatory frameworks to ensure the provision of accessible and affordable health services. Specifically, the National Health (Pharmaceutical Benefits) Regulations (Amendment) 1990 were introduced to refine the administration of pharmaceutical benefits under the Act. The primary issue these amendments aimed to resolve was the potential for hoarding or stockpiling of medications towards the end of the Safety Net year, which undermines the equitable distribution of pharmaceutical benefits. By extending the permissible period between the filling of a prescription and the next repeat prescription from one day to three days, the amendment seeks to mitigate this issue while still allowing for necessary medical provisions as prescribed by practitioners. The regulations also ensure that appropriate documentation is maintained when a second supply occurs within this extended period, reflecting a balance between regulatory oversight and patient care needs.
Scope and Application
The National Health (Pharmaceutical Benefits) Regulations (Amendment) pertains to the National Health Act 1953, which applies broadly across Australia, governing the provision of pharmaceutical benefits under the Medicare scheme. This Act applies to individuals, medical practitioners, pharmacists, and other entities involved in the supply and administration of pharmaceutical benefits within Australia. The amendment in question specifically targets regulation 25, which governs the permissible period between the filling of a prescription and the next repeat prescription of the same drug. The amendment extends this period from the next day to three clear days, with certain exceptions where medical necessity dictates a shorter interval. This regulation is designed to mitigate the risk of hoarding medications towards the end of the Safety Net year, ensuring equitable access to pharmaceutical benefits while maintaining patient care standards. The amendment, effective from 1 November 1990, aims to balance the need for efficient pharmaceutical management with the imperative to provide necessary medical treatments.
Key Provisions
The National Health (Pharmaceutical Benefits) Regulations (Amendment) primarily focuses on amending regulation 25 under the National Health (Pharmaceutical Benefits) Regulations, as part of the National Health Act 1953. Section 105(a) of the Act allows the regulations to prescribe the terms and conditions for supplying pharmaceutical benefits, and this amendment specifically targets the timing between the filling of a prescription and the next repeat prescription of the same drug (section 140). The amendment extends the permissible period from the next day to three clear days. This change is aimed at curbing the potential for hoarding or squirrelling of drugs towards the end of the Safety Net year (subsection 105(a)). The Safety Net, as outlined in Division 1A of the Act, provides free pharmaceutical benefits to individuals or families who purchase 25 prescriptions within a calendar year for the remainder of that year.
The Regulations impose specific obligations on medical practitioners and suppliers. Medical practitioners must prescribe the necessity for the supply of the benefit if a second supply is made within the three-day period, ensuring that the supply is essential for the treatment of the patient. In cases where the benefit is destroyed, lost, or stolen, the regulation also allows for further supply within the three days. Suppliers are required to appropriately endorse and sign the prescription when a second supply is made within this timeframe (regulation 25). This ensures that the supply of the benefit is documented and justified in accordance with the amended regulation.
The National Health Act 1953 outlines potential consequences for non-compliance with its regulations. Offences and penalties are not explicitly stated in the explanatory statement, but breaches of regulations typically result in civil or criminal consequences, which can include fines and other penalties as determined by relevant authorities. The precise nature and extent of these penalties would depend on the specific breach and the jurisdiction in which it occurs. However, adherence to the regulations is critical to avoid any legal repercussions and to ensure the smooth operation of the pharmaceutical benefits system.